Mirae Asset Global Investments Co., Ltd.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-24
Total Holdings
1,827
Total Value
23729973945
Accession Number
0000905148-25-001297
Form Type
13F-HR
Manager Name
Mirae Asset Global Investments Co., Ltd.
Data Enrichment
87% identified
1,585 identified242 unidentified

Holdings

1,827 positions
Manager:
Search and click to pin securities to the top
Page 75 of 80
CODEXIS, INC.
Shares:
2772(+2.2%)
Value:
$7.8M(-42.4%)
IRONWOOD PHARMACEUTICALS INC
Shares:
5499(+3.1%)
Value:
$7.8M(-67.3%)
iTeos Therapeutics, Inc.
Shares:
1222(+0.4%)
Value:
$7.7M(-13.3%)
Y-mAbs Therapeutics, Inc.
Shares:
1505(+0.8%)
Value:
$7.2M(-39.4%)
Neurogene Inc.
Shares:
491(-0.8%)
Value:
$7.1M(-37.3%)
Tevogen Bio Holdings Inc.
Shares:
5857(+0.4%)
Value:
$7.0M(+17.0%)
Corvus Pharmaceuticals, Inc.
Shares:
2048(-4.3%)
Value:
$6.9M(-37.9%)
LEXICON PHARMACEUTICALS, INC.
Shares:
12096(+0.4%)
Value:
$6.9M(-25.9%)
Inhibrx Biosciences, Inc.
Shares:
488(+1.2%)
Value:
$6.9M(-4.8%)
Voyager Therapeutics, Inc.
Shares:
1828(+0.4%)
Value:
$6.7M(-36.1%)
AC Immune SA
Shares:
3309(+0.4%)
Value:
$6.6M(-27.2%)
Foghorn Therapeutics Inc.
Shares:
1861(+0.4%)
Value:
$6.6M(-26.6%)
CARGO Therapeutics, Inc.
Shares:
1540(+0.4%)
Value:
$6.4M(-70.3%)
COMPASS Pathways plc
Shares:
2013(+18.8%)
Value:
$5.9M(-12.4%)
AMARIN CORP PLC\UK
Shares:
13400(+0.5%)
Value:
$5.9M(-1.3%)
294628102
Shares:
3490(+0.0%)
Value:
$5.6M(-8.0%)
Neumora Therapeutics, Inc.
Shares:
5406(+0.4%)
Value:
$5.6M(-90.9%)
4D Molecular Therapeutics, Inc.
Shares:
1533(-0.5%)
Value:
$5.6M(-34.9%)
Tango Therapeutics, Inc.
Shares:
3733(+4.3%)
Value:
$5.5M(-50.9%)
Silence Therapeutics plc
Shares:
1573(+0.4%)
Value:
$5.4M(-51.3%)